{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "\n",
    "load_dotenv()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "e:\\LLama-Index\\venv\\lib\\site-packages\\tqdm\\auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing ai in radiology.pdf...\n",
      "Processing cancer immunotherapy.pdf...\n",
      "Processing covid-19.pdf...\n",
      "Processing diabetes.pdf...\n",
      "Processing Hypertension treatment.pdf...\n",
      "Extracted text from 5 PDFs. Saved to medical_papers/extracted_text.json\n"
     ]
    }
   ],
   "source": [
    "from unstructured.partition.pdf import partition_pdf\n",
    "from unstructured.staging.base import convert_to_dict\n",
    "import json\n",
    "import os\n",
    "\n",
    "def extract_text_from_pdf(filepath):\n",
    "    \"\"\"Extract text from a PDF file with error handling\"\"\"\n",
    "    try:\n",
    "        elements = partition_pdf(filepath, strategy=\"auto\")\n",
    "        data = convert_to_dict(elements)\n",
    "        return \"\\n\".join([item[\"text\"] for item in data if \"text\" in item])\n",
    "    except Exception as e:\n",
    "        print(f\"Error processing {filepath}: {str(e)}\")\n",
    "        return None\n",
    "\n",
    "# Process all PDFs in medical_papers directory\n",
    "medical_data = {}\n",
    "pdf_folder = \"medical_papers\"\n",
    "\n",
    "for filename in os.listdir(pdf_folder):\n",
    "    if filename.endswith(\".pdf\"):\n",
    "        pmcid = filename.split(\".\")[0]\n",
    "        filepath = os.path.join(pdf_folder, filename)\n",
    "        print(f\"Processing {filename}...\")\n",
    "        \n",
    "        text = extract_text_from_pdf(filepath)\n",
    "        if text:\n",
    "            medical_data[pmcid] = text\n",
    "\n",
    "# Save results\n",
    "with open(os.path.join(pdf_folder, \"extracted_text.json\"), \"w\") as f:\n",
    "    json.dump(medical_data, f, indent=2)\n",
    "\n",
    "print(f\"Extracted text from {len(medical_data)} PDFs. Saved to medical_papers/extracted_text.json\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Text cleaning complete. Data saved to 'medical_papers/cleaned_data.json'.\n"
     ]
    }
   ],
   "source": [
    "import re\n",
    "\n",
    "def clean_text(text):\n",
    "    \"\"\"Clean extracted text.\"\"\"\n",
    "    # Remove headers/footers\n",
    "    text = re.sub(r'Page \\d+ of \\d+', '', text)\n",
    "    # Remove multiple newlines\n",
    "    text = re.sub(r'\\n+', '\\n', text)\n",
    "    # Remove references section\n",
    "    text = re.sub(r'References.*', '', text, flags=re.DOTALL)\n",
    "    # Remove special characters\n",
    "    text = re.sub(r'[^\\x00-\\x7F]+', ' ', text)\n",
    "    return text.strip()\n",
    "\n",
    "# Clean all extracted text\n",
    "cleaned_data = {pmcid: clean_text(text) for pmcid, text in medical_data.items()}\n",
    "\n",
    "# Save cleaned data\n",
    "with open(\"medical_papers/cleaned_data.json\", \"w\") as f:\n",
    "    json.dump(cleaned_data, f)\n",
    "\n",
    "print(\"Text cleaning complete. Data saved to 'medical_papers/cleaned_data.json'.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "PMCID: ai in radiology\n",
      "Sample Text:\n",
      " Edited by: Yiannis Kyratsis, Vrije Universiteit Amsterdam, Netherlands\n",
      "Reviewed by: Niamh Lennox-Chhugani, International Foundation for Integrated Care (IFIC), United Kingdom Ram Bajpai, Keele University, United Kingdom\n",
      "Correspondence: Christina Malamateniou christina.malamateniou@city.ac.uk\n",
      " These authors have contributed equally to this work and share last authorship\n",
      "Specialty section: This article was submitted to Health Technology Innovation, a section of the journal Frontiers in Digital Hea ...\n"
     ]
    }
   ],
   "source": [
    "# Load cleaned data\n",
    "with open(\"medical_papers/cleaned_data.json\", \"r\") as f:\n",
    "    cleaned_data = json.load(f)\n",
    "\n",
    "# Print a sample\n",
    "for pmcid, text in list(cleaned_data.items())[:1]:  # Inspect the first document\n",
    "    print(f\"PMCID: {pmcid}\")\n",
    "    print(\"Sample Text:\\n\", text[:500], \"...\")  # Show first 500 characters"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Created 469 chunks from 5 documents.\n"
     ]
    }
   ],
   "source": [
    "from llama_index.core.node_parser import SimpleNodeParser\n",
    "from llama_index.core.schema import Document\n",
    "import json\n",
    "\n",
    "# Load cleaned data from JSON file\n",
    "with open(\"medical_papers/extracted_text.json\", \"r\") as f:\n",
    "    cleaned_data = json.load(f)\n",
    "\n",
    "# Initialize node parser\n",
    "node_parser = SimpleNodeParser.from_defaults(chunk_size=512, chunk_overlap=20)\n",
    "\n",
    "# Create nodes from cleaned text\n",
    "nodes = []\n",
    "for pmcid, text in cleaned_data.items():\n",
    "    document = Document(text=text, id_=pmcid)  # Use `id_` instead of `doc_id`\n",
    "    nodes.extend(node_parser.get_nodes_from_documents([document]))\n",
    "\n",
    "print(f\"Created {len(nodes)} chunks from {len(cleaned_data)} documents.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index built successfully!\n"
     ]
    }
   ],
   "source": [
    "groq_api = os.getenv(\"GROQ_API_KEY\")\n",
    "from llama_index.core import VectorStoreIndex, Settings\n",
    "from llama_index.llms.groq import Groq  # Make sure you have this installed\n",
    "\n",
    "# Set up Groq LLM\n",
    "llm = Groq(model=\"llama-3.1-8b-instant\", api_key=groq_api)\n",
    "\n",
    "# Configure global settings\n",
    "Settings.llm = llm\n",
    "Settings.embed_model = \"local:BAAI/bge-small-en-v1.5\"  # Local embedding model\n",
    "\n",
    "# Create index from existing chunks\n",
    "index = VectorStoreIndex(nodes)  # nodes = your pre-created chunks\n",
    "print(\"Index built successfully!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Diabetes Treatments:\n",
      " There is no information provided about the latest treatments for Type 2 Diabetes in the given context. The context appears to be related to diabetes insipidus, a condition distinct from Type 2 Diabetes.\n",
      "Hypertension Risk Factors:\n",
      " According to the provided information, the key risk factors for hypertension that can affect disease outcomes include age, comorbidities, musculoskeletal disease, and other factors beyond pulmonary arterial hypertension (PAH) severity. Additionally, functional class, 6-minute walk distance (6MWD), and BNP or NT-proBNP levels are also considered important noninvasive prognostic measures.\n"
     ]
    }
   ],
   "source": [
    "query_engine = index.as_query_engine()\n",
    "\n",
    "# Query 1: Diabetes Treatment\n",
    "response = query_engine.query(\n",
    "    \"What are the latest treatments for Type 2 Diabetes mentioned in these papers?\"\n",
    ")\n",
    "print(\"Diabetes Treatments:\\n\", response)\n",
    "\n",
    "# Query 2: Hypertension Risk Factors\n",
    "response = query_engine.query(\n",
    "    \"What are the key risk factors for hypertension according to these papers?\"\n",
    ")\n",
    "print(\"Hypertension Risk Factors:\\n\", response)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Diabetes Insipidus Treatments:\n",
      " The latest treatments for diabetes insipidus mentioned in these papers, particularly after pituitary surgery, involve the use of desmopressin. Desmopressin is an analogue of arginine vasopressin, which helps to regulate the amount of water in the body by promoting water reabsorption in the kidneys. It is often used to treat central diabetes insipidus, a common complication after pituitary surgery.\n",
      "Pulmonary Arterial Hypertension Treatment:\n",
      " Initial combination therapy with early and frequent reassessment is recommended. Medications targeting four pathways are now available, and maximal medical therapy is now four-drug therapy.\n",
      "COVID-19 Vaccine Updates:\n",
      " The progress in vaccine development against SARS-CoV-2 has been remarkable due to advancements in molecular and biologic sciences. Various vaccine platforms, including whole virus vaccines, viral vector vaccines, and nucleic acid vaccines, are being developed to target the viral spike proteins and generate antibodies. However, the therapeutic efficacy of these vaccines varies due to their pharmacodynamic individualities, and some COVID-19 variants may be resistant to antibodies generated by current vaccines.\n",
      "\n",
      "Studies in special populations, such as young children, immunocompromised patients, pregnant individuals, and others, are pending results, as the current clinical use of these vaccines has been through emergency use authorization. Combination approaches, molecularly modified vaccination approaches, and vaccines conferring longer periods of immunity are being investigated to address these concerns.\n",
      "\n",
      "The ongoing transformation of SARS-CoV-2 and its variants poses new challenges for vaccine development, including breakthrough infections. Booster doses, combination vaccine approaches, and other modalities are being discussed to address these concerns. This review provides an updated account of currently available vaccines and those in advanced development, including their composition and mechanisms of action, as well as a discussion on the use of vaccines in special populations.\n",
      "Nanoparticles in Cancer Immunotherapy:\n",
      " Nanoparticles are being engineered to reshape the tumor microenvironment, enhancing immunotherapy by facilitating targeted delivery and immune modulation. They can suppress fibroblast activation, promote M1 macrophage polarization, aid dendritic cell maturation, and encourage T cell infiltration. Additionally, biomimetic nanoparticles can increase the internalization of immunomodulatory agents in immune cells, such as dendritic cells.\n",
      "AI in Radiology:\n",
      " The key applications of AI in radiology mentioned in these papers include image recognition tasks, computer-aided detection and diagnosis, and navigating digital health systems.\n"
     ]
    }
   ],
   "source": [
    "# Query 1: Diabetes Treatment\n",
    "response = query_engine.query(\n",
    "    \"What are the latest treatments for diabetes insipidus mentioned in these papers, particularly after pituitary surgery?\"\n",
    ")\n",
    "print(\"Diabetes Insipidus Treatments:\\n\", response)\n",
    "\n",
    "# Query 2: Hypertension Treatment\n",
    "response = query_engine.query(\n",
    "    \"What are the recommended treatment algorithms for pulmonary arterial hypertension according to these papers?\"\n",
    ")\n",
    "print(\"Pulmonary Arterial Hypertension Treatment:\\n\", response)\n",
    "\n",
    "# Query 3: COVID-19 Vaccines\n",
    "response = query_engine.query(\n",
    "    \"What are the latest updates on COVID-19 vaccine development, including variants and considerations for special populations?\"\n",
    ")\n",
    "print(\"COVID-19 Vaccine Updates:\\n\", response)\n",
    "\n",
    "# Query 4: Cancer Immunotherapy\n",
    "response = query_engine.query(\n",
    "    \"How are nanoparticles being used in cancer immunotherapy and tumor microenvironment remodeling?\"\n",
    ")\n",
    "print(\"Nanoparticles in Cancer Immunotherapy:\\n\", response)\n",
    "\n",
    "# Query 5: AI in Radiology\n",
    "response = query_engine.query(\n",
    "    \"What are the key applications of AI in radiology mentioned in these papers?\"\n",
    ")\n",
    "print(\"AI in Radiology:\\n\", response)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\u001b[1;36mDiabetes Insipidus Treatments\u001b[0m\n",
      "\u001b[1;32m=============================\u001b[0m\n",
      "\u001b[0;37mThe latest treatments for diabetes insipidus mentioned in these papers,\n",
      "particularly after pituitary surgery, involve the use of desmopressin.\n",
      "Desmopressin is an analogue of arginine vasopressin, which helps to regulate\n",
      "water balance in the body. It is often used to treat central diabetes insipidus,\n",
      "a condition that can occur after pituitary surgery.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mPulmonary Arterial Hypertension Treatment\u001b[0m\n",
      "\u001b[1;32m=========================================\u001b[0m\n",
      "\u001b[0;37mInitial combination therapy with early and frequent reassessment is recommended.\n",
      "Medications targeting four pathways are now available, and maximal medical\n",
      "therapy is now four-drug therapy.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mCOVID-19 Vaccine Updates\u001b[0m\n",
      "\u001b[1;32m========================\u001b[0m\n",
      "\u001b[0;37mThe progress in vaccine development against SARS-CoV-2 has been remarkable due\n",
      "to advancements in molecular and biologic sciences. Various vaccine platforms,\n",
      "including whole virus vaccines, viral vector vaccines, and nucleic acid\n",
      "vaccines, are being developed to target the viral spike proteins and generate\n",
      "antibodies. However, the therapeutic efficacy of these vaccines varies due to\n",
      "their pharmacodynamic individualities, and some COVID-19 variants may be\n",
      "resistant to antibodies generated by current vaccines.  Studies in special\n",
      "populations, such as young children, immunocompromised patients, pregnant\n",
      "individuals, and others, are pending results, as the current clinical use of\n",
      "these vaccines has been through emergency use authorization. Combination\n",
      "approaches, molecularly modified vaccination approaches, and vaccines conferring\n",
      "longer periods of immunity are being investigated to address these concerns.\n",
      "Booster doses, combination vaccine approaches, and other modalities are being\n",
      "discussed to address the challenges posed by the continual transformation of\n",
      "SARS-CoV-2 and its variants, as well as breakthrough infections. This review\n",
      "provides an updated account of currently available vaccines and those in\n",
      "advanced development, including their composition and mechanisms of action, as\n",
      "well as a discussion on the use of vaccines in special populations.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mNanoparticles in Cancer Immunotherapy\u001b[0m\n",
      "\u001b[1;32m=====================================\u001b[0m\n",
      "\u001b[0;37mNanoparticles are being engineered to reshape the tumor microenvironment,\n",
      "enhancing immunotherapy by facilitating targeted delivery and immune modulation.\n",
      "They can suppress fibroblast activation, promote M1 macrophage polarization, aid\n",
      "dendritic cell maturation, and encourage T cell infiltration. Additionally,\n",
      "biomimetic nanoparticles increase the internalization of immunomodulatory agents\n",
      "in immune cells, while exosomes are being explored to regulate the tumor\n",
      "microenvironment and immune-related cells.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mAI in Radiology\u001b[0m\n",
      "\u001b[1;32m===============\u001b[0m\n",
      "\u001b[0;37mThe key applications of AI in radiology mentioned in these papers include image\n",
      "recognition tasks, computer-aided detection and diagnosis, and navigating\n",
      "digital health systems.\u001b[0m\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import textwrap\n",
    "\n",
    "# Function to print responses in a clean, wrapped format\n",
    "def print_response(title, response):\n",
    "    print(f\"\\n\\033[1;36m{title}\\033[0m\")  # Cyan color for title\n",
    "    print(\"\\033[1;32m\" + \"=\" * len(title) + \"\\033[0m\")  # Green line under title\n",
    "    wrapped_text = textwrap.fill(response, width=80)  # Wrap text to 80 characters\n",
    "    print(\"\\033[0;37m\" + wrapped_text + \"\\033[0m\")  # White text for response\n",
    "    print(\"\\n\")\n",
    "\n",
    "# Query 1: Diabetes Treatment\n",
    "response = query_engine.query(\n",
    "    \"What are the latest treatments for diabetes insipidus mentioned in these papers, particularly after pituitary surgery?\"\n",
    ")\n",
    "print_response(\"Diabetes Insipidus Treatments\", str(response))\n",
    "\n",
    "# Query 2: Hypertension Treatment\n",
    "response = query_engine.query(\n",
    "    \"What are the recommended treatment algorithms for pulmonary arterial hypertension according to these papers?\"\n",
    ")\n",
    "print_response(\"Pulmonary Arterial Hypertension Treatment\", str(response))\n",
    "\n",
    "# Query 3: COVID-19 Vaccines\n",
    "response = query_engine.query(\n",
    "    \"What are the latest updates on COVID-19 vaccine development, including variants and considerations for special populations?\"\n",
    ")\n",
    "print_response(\"COVID-19 Vaccine Updates\", str(response))\n",
    "\n",
    "# Query 4: Cancer Immunotherapy\n",
    "response = query_engine.query(\n",
    "    \"How are nanoparticles being used in cancer immunotherapy and tumor microenvironment remodeling?\"\n",
    ")\n",
    "print_response(\"Nanoparticles in Cancer Immunotherapy\", str(response))\n",
    "\n",
    "# Query 5: AI in Radiology\n",
    "response = query_engine.query(\n",
    "    \"What are the key applications of AI in radiology mentioned in these papers?\"\n",
    ")\n",
    "print_response(\"AI in Radiology\", str(response))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\u001b[1;36mRole of Desmopressin in Diabetes Insipidus\u001b[0m\n",
      "\u001b[1;32m==========================================\u001b[0m\n",
      "\u001b[0;37mDesmopressin is used to manage diabetes insipidus by replacing the deficient\n",
      "antidiuretic hormone (ADH) and thereby reducing urine production. It is\n",
      "administered intranasally or subcutaneously, and has been shown to be effective\n",
      "in treating central diabetes insipidus, particularly in infants and young\n",
      "children.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mFirst-Line Medications for Pulmonary Arterial Hypertension\u001b[0m\n",
      "\u001b[1;32m==========================================================\u001b[0m\n",
      "\u001b[0;37mThe first-line medications recommended for pulmonary arterial hypertension\n",
      "typically involve a combination of therapies targeting different pathways. These\n",
      "include endothelin-1 receptor antagonists, such as ambrisentan, bosentan, and\n",
      "macitentan, and guanylyl cyclase stimulators, like riociguat.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mLong-Term Outcomes for Diabetes Insipidus\u001b[0m\n",
      "\u001b[1;32m=========================================\u001b[0m\n",
      "\u001b[0;37mClose monitoring is required to evaluate the response to treatment and to\n",
      "determine whether the diabetes insipidus is transient or permanent. This\n",
      "suggests that the long-term outcomes for patients with diabetes insipidus after\n",
      "pituitary surgery can vary depending on the duration and severity of the\n",
      "condition.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mComorbidities in Pulmonary Arterial Hypertension\u001b[0m\n",
      "\u001b[1;32m================================================\u001b[0m\n",
      "\u001b[0;37mThe common comorbidities associated with pulmonary arterial hypertension include\n",
      "hypertension, diabetes, obesity, sleep medical conditions associated with left\n",
      "heart disease, apnoea, atrial fibrillation, and coronary artery disease.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mOverlapping Treatments for Diabetes and Hypertension\u001b[0m\n",
      "\u001b[1;32m====================================================\u001b[0m\n",
      "\u001b[0;37mThere are no overlapping treatment strategies for diabetes insipidus and\n",
      "pulmonary arterial hypertension.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mAI in COVID-19 Vaccine Development\u001b[0m\n",
      "\u001b[1;32m==================================\u001b[0m\n",
      "\u001b[0;37mThere is no mention of AI being used to improve COVID-19 vaccine development or\n",
      "distribution in the provided context information. However, it does mention the\n",
      "use of various technologies and platforms, such as autologous cell therapy,\n",
      "molecularly defined mechanisms, and recombinant protein production, to develop\n",
      "and manufacture COVID-19 vaccines.\u001b[0m\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Specific Detail Questions\n",
    "response = query_engine.query(\n",
    "    \"What is the role of desmopressin in treating diabetes insipidus after pituitary surgery?\"\n",
    ")\n",
    "print_response(\"Role of Desmopressin in Diabetes Insipidus\", str(response))\n",
    "\n",
    "response = query_engine.query(\n",
    "    \"What are the first-line medications recommended for pulmonary arterial hypertension?\"\n",
    ")\n",
    "print_response(\"First-Line Medications for Pulmonary Arterial Hypertension\", str(response))\n",
    "\n",
    "# Broad Theme Questions\n",
    "response = query_engine.query(\n",
    "    \"What are the long-term outcomes for patients with diabetes insipidus after pituitary surgery?\"\n",
    ")\n",
    "print_response(\"Long-Term Outcomes for Diabetes Insipidus\", str(response))\n",
    "\n",
    "response = query_engine.query(\n",
    "    \"What are the common comorbidities associated with pulmonary arterial hypertension?\"\n",
    ")\n",
    "print_response(\"Comorbidities in Pulmonary Arterial Hypertension\", str(response))\n",
    "\n",
    "# Cross-Document Questions\n",
    "response = query_engine.query(\n",
    "    \"Are there any overlapping treatment strategies for diabetes insipidus and pulmonary arterial hypertension?\"\n",
    ")\n",
    "print_response(\"Overlapping Treatments for Diabetes and Hypertension\", str(response))\n",
    "\n",
    "response = query_engine.query(\n",
    "    \"How has AI been used to improve COVID-19 vaccine development or distribution?\"\n",
    ")\n",
    "print_response(\"AI in COVID-19 Vaccine Development\", str(response))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\u001b[1;36mDesmopressin Dosages and Administration\u001b[0m\n",
      "\u001b[1;32m=======================================\u001b[0m\n",
      "\u001b[0;37mDesmopressin is typically administered orally or via injection, and its efficacy\n",
      "and safety have been demonstrated in patients with central diabetes insipidus.\n",
      "The duration of antidiuretic action of desmopressin can vary, and high doses may\n",
      "require more frequent administration. A shortened duration of action has been\n",
      "observed in patients requiring high doses of peroral antidiuretic drugs.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mFirst-Line Medications for Pulmonary Arterial Hypertension\u001b[0m\n",
      "\u001b[1;32m==========================================================\u001b[0m\n",
      "\u001b[0;37mMedications targeting four pathways are now available for the treatment of\n",
      "pulmonary arterial hypertension. These pathways include endothelin-1, nitric\n",
      "oxide, prostacyclin, and bone morphogenetic protein/activin signalling.   The\n",
      "specific first-line medications for pulmonary arterial hypertension typically\n",
      "involve a combination of therapies targeting these pathways. However, the exact\n",
      "medications used can vary depending on the individual patient's needs and the\n",
      "severity of their condition.  In general, medications that target the\n",
      "endothelin-1 pathway, such as endothelin receptor antagonists, are often used in\n",
      "combination with other therapies. Medications that target the nitric oxide\n",
      "pathway, such as phosphodiesterase-5 inhibitors, are also commonly used.\n",
      "Prostacyclin pathway agents, including parenteral prostacyclin pathway agents,\n",
      "are often used in combination with other therapies, particularly for patients\n",
      "with more severe disease.  Bone morphogenetic protein/activin signalling pathway\n",
      "agents are also available, but their use may be more limited compared to the\n",
      "other pathways. The specific medications used and their mechanisms of action can\n",
      "be tailored to the individual patient's needs and response to treatment.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mChallenges in COVID-19 Vaccine Development\u001b[0m\n",
      "\u001b[1;32m==========================================\u001b[0m\n",
      "\u001b[0;37mThe development of COVID-19 vaccines for immunocompromised populations poses\n",
      "several challenges. These individuals often have weakened immune systems, making\n",
      "it difficult for their bodies to mount an effective response to vaccination. As\n",
      "a result, the therapeutic efficacy of these vaccines may be reduced in this\n",
      "population.  To address these challenges, researchers are investigating\n",
      "combination approaches, molecularly modified vaccination approaches, and\n",
      "vaccines conferring longer periods of immunity. These strategies aim to enhance\n",
      "the immune response in immunocompromised individuals and provide longer-lasting\n",
      "protection against COVID-19.  Additionally, studies are being conducted to\n",
      "better understand the pharmacodynamic individualities of these vaccines in\n",
      "immunocompromised populations. This knowledge will help inform the development\n",
      "of more effective vaccination strategies for this group.  Furthermore, the\n",
      "emergence of COVID-19 variants that may be resistant to antibodies generated by\n",
      "current vaccines also poses a challenge. Researchers are working to develop\n",
      "vaccines that can provide broad-spectrum protection against these variants,\n",
      "which is particularly important for immunocompromised individuals who may be\n",
      "more susceptible to severe disease.  Overall, the development of COVID-19\n",
      "vaccines for immunocompromised populations requires a nuanced understanding of\n",
      "their unique immune profiles and the challenges they pose. By addressing these\n",
      "challenges through innovative vaccine development strategies and rigorous\n",
      "research, it is possible to improve the therapeutic efficacy of these vaccines\n",
      "and provide better protection against COVID-19 for this vulnerable group.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mNanoparticles in Cancer Immunotherapy\u001b[0m\n",
      "\u001b[1;32m=====================================\u001b[0m\n",
      "\u001b[0;37mResearchers have been exploring various types of nanoparticles for cancer\n",
      "immunotherapy, including biomimetic nanocarriers, exosomes, and stimuli-\n",
      "responsive nanocarriers. Biomimetic nanocarriers, which mimic the structure and\n",
      "function of natural cells, have shown promise in delivering immunomodulatory\n",
      "compounds and remodeling the tumor microenvironment. Exosomes, which are\n",
      "naturally secreted by cells or engineered in the laboratory, have also been\n",
      "investigated for their potential to regulate the immune system in cancer\n",
      "therapy.  Stimuli-responsive nanocarriers, on the other hand, are designed to\n",
      "respond to specific stimuli, such as pH or redox changes, to release their cargo\n",
      "and induce immunogenic cell death. These nanoparticles have been shown to\n",
      "enhance the potential of cancer immunotherapy by regulating dendritic cells and\n",
      "T cells, and promoting M1 polarization of macrophages.  In terms of\n",
      "effectiveness, the specific type of nanoparticle used can impact the outcome of\n",
      "cancer immunotherapy. For example, biomimetic nanocarriers may be more effective\n",
      "at delivering immunomodulatory compounds to specific cells within the tumor\n",
      "microenvironment, while exosomes may be more effective at regulating the immune\n",
      "system on a systemic level. Stimuli-responsive nanocarriers, meanwhile, may be\n",
      "more effective at inducing immunogenic cell death and promoting anti-tumor\n",
      "immune responses.  Overall, the effectiveness of nanoparticles in cancer\n",
      "immunotherapy depends on their specific design, composition, and functionality,\n",
      "as well as the type of cancer being treated and the individual patient's immune\n",
      "response.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mAI Algorithms in Radiology\u001b[0m\n",
      "\u001b[1;32m==========================\u001b[0m\n",
      "\u001b[0;37mConvolutional neural networks (CNNs) are mentioned as being used in image\n",
      "recognition tasks for medical imaging analysis. They learn iteratively until\n",
      "acceptable performance is achieved relative to the previous interpretive\n",
      "standard.\u001b[0m\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Diabetes Insipidus\n",
    "response = query_engine.query(\n",
    "    \"What are the recommended dosages and administration methods for desmopressin in treating diabetes insipidus after pituitary surgery?\"\n",
    ")\n",
    "print_response(\"Desmopressin Dosages and Administration\", str(response))\n",
    "\n",
    "# Pulmonary Arterial Hypertension\n",
    "response = query_engine.query(\n",
    "    \"What are the specific first-line medications for pulmonary arterial hypertension, and how do they differ in mechanism of action?\"\n",
    ")\n",
    "print_response(\"First-Line Medications for Pulmonary Arterial Hypertension\", str(response))\n",
    "\n",
    "# COVID-19 Vaccines\n",
    "response = query_engine.query(\n",
    "    \"What are the specific challenges in developing COVID-19 vaccines for immunocompromised populations, and how are they addressed?\"\n",
    ")\n",
    "print_response(\"Challenges in COVID-19 Vaccine Development\", str(response))\n",
    "\n",
    "# Cancer Immunotherapy\n",
    "response = query_engine.query(\n",
    "    \"What are the specific types of nanoparticles used in cancer immunotherapy, and how do they differ in effectiveness?\"\n",
    ")\n",
    "print_response(\"Nanoparticles in Cancer Immunotherapy\", str(response))\n",
    "\n",
    "# AI in Radiology\n",
    "response = query_engine.query(\n",
    "    \"What are the specific AI algorithms mentioned for analyzing medical imaging, and how accurate are they?\"\n",
    ")\n",
    "print_response(\"AI Algorithms in Radiology\", str(response))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\u001b[1;36mDesmopressin in Pediatric Diabetes Insipidus\u001b[0m\n",
      "\u001b[1;32m============================================\u001b[0m\n",
      "\u001b[0;37mDesmopressin is a synthetic analogue of vasopressin, commonly used to treat\n",
      "diabetes insipidus. In pediatric patients, the efficacy and safety of\n",
      "desmopressin have been evaluated in various studies.  For infants with central\n",
      "diabetes insipidus, subcutaneous administration of desmopressin has been found\n",
      "to be effective. A study published in the Journal of Pediatric Endocrinology and\n",
      "Metabolism reported the use of subcutaneous desmopressin in infants, with a\n",
      "dosage of 0.05-0.1 mg per day.  Intranasal administration of desmopressin has\n",
      "also been studied in pediatric patients. A review article mentioned the efficacy\n",
      "and safety of intranasal desmopressin in infants with neurogenic diabetes\n",
      "insipidus.  Regarding dosages, a multicenter open-label dose-titration study\n",
      "found that orally disintegrating tablets of desmopressin were effective in\n",
      "patients with central diabetes insipidus, with a starting dose of 0.05 mg per\n",
      "day.  As for side effects, a study on the treatment of diabetes insipidus with\n",
      "1-deamino-8-D-arginine-vasopressin mentioned that high doses of peroral\n",
      "antidiuretic drugs can lead to a shortened duration of action of desmopressin.\n",
      "However, there is limited information on contraindications for desmopressin in\n",
      "pediatric patients with diabetes insipidus. Further research is needed to fully\n",
      "understand the safety profile of desmopressin in this population.  In terms of\n",
      "administration methods, intranasal and subcutaneous routes have been studied in\n",
      "pediatric patients. Orally disintegrating tablets have also been evaluated in a\n",
      "multicenter study.  It is essential to note that individualized dosing and\n",
      "administration methods may be necessary to achieve optimal results in pediatric\n",
      "patients with diabetes insipidus.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mCombination Therapies for Pulmonary Arterial Hypertension\u001b[0m\n",
      "\u001b[1;32m=========================================================\u001b[0m\n",
      "\u001b[0;37mLarger improvements in patients with pulmonary arterial hypertension have been\n",
      "seen with combination therapy compared to monotherapy. This is due to the fact\n",
      "that combination therapy can target multiple pathways involved in the disease,\n",
      "such as endothelin-1, nitric oxide, prostacyclin, and bone morphogenetic\n",
      "protein/activin signalling.  While specific success rates for combination\n",
      "therapies are not provided, it is mentioned that efficacy has generally been\n",
      "greater with therapeutic combinations and with parenteral therapy compared with\n",
      "monotherapy or nonparenteral therapies. This suggests that combination therapies\n",
      "are effective in improving functional class, exercise capacity, haemodynamics,\n",
      "and survival in patients with PAH.  Regarding pediatric patients, there is no\n",
      "specific information provided in the context regarding guidelines for pediatric\n",
      "patients. However, it is mentioned that most patients with PAH are candidates\n",
      "for oral or oral plus parenteral combination therapy from the time of diagnosis,\n",
      "along with early reassessment and escalation in therapy when indicated. This\n",
      "suggests that combination therapy may be beneficial for pediatric patients as\n",
      "well, but further research and guidelines are needed to determine the optimal\n",
      "treatment approach for this population.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mStrategies for COVID-19 Vaccines in Immunocompromised Populations\u001b[0m\n",
      "\u001b[1;32m=================================================================\u001b[0m\n",
      "\u001b[0;37mHigher doses or boosters can be employed to enhance immunogenicity in\n",
      "immunocompromised patients. Additionally, booster doses, combination vaccine\n",
      "approaches, and other modalities are being discussed for improving COVID-19\n",
      "vaccine efficacy in these populations.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mBiomimetic Nanocarriers in Cancer Immunotherapy\u001b[0m\n",
      "\u001b[1;32m===============================================\u001b[0m\n",
      "\u001b[0;37mThe use of biomimetic nanocarriers in cancer immunotherapy has shown promising\n",
      "clinical outcomes, including the enhancement of chemotherapy, impairment of\n",
      "relapse, and prevention of cancer invasion. Additionally, these nanocarriers\n",
      "have been found to effectively suppress cancer progression in vivo, making them\n",
      "potential candidates for the development of cancer vaccines.  In terms of\n",
      "specific clinical outcomes, studies have demonstrated that biomimetic\n",
      "nanocarriers can induce the maturation of dendritic cells and enhance the\n",
      "infiltration of effector cells, leading to improved cancer immunotherapy.\n",
      "Furthermore, the use of these nanocarriers has been shown to downregulate immune\n",
      "evasion factors, such as PD-L1, and prevent T cell exhaustion.  Regarding\n",
      "ongoing clinical trials, several studies have been mentioned in the context\n",
      "information, including a study by Pan et al. (2022) on a heterogenic membrane-\n",
      "based biomimetic hybrid nanoplat- form for combining radiotherapy and\n",
      "immunotherapy against breast cancer. Another study by Wang et al. (2022)\n",
      "explored an intelligent biomimetic nanoplatform for systemic treatment of\n",
      "metastatic triple-negative breast cancer via enhanced EGFR-Targeted therapy and\n",
      "immunotherapy. Additionally, a study by Li et al. (2022) investigated\n",
      "multifunctional biomimetic nanovaccines based on photothermal and weak-\n",
      "immunostimulatory nanoparticulate cores for the immunotherapy of solid tumors.\u001b[0m\n",
      "\n",
      "\n",
      "\n",
      "\u001b[1;36mCNNs in Radiology\u001b[0m\n",
      "\u001b[1;32m=================\u001b[0m\n",
      "\u001b[0;37mConvolutional neural networks (CNNs) have been successfully applied in radiology\n",
      "for image recognition tasks, particularly in image analysis and interpretation.\n",
      "They have shown great potential in detecting abnormalities in medical imaging by\n",
      "learning to identify patterns and features within images.  In radiology, CNNs\n",
      "have been used for various applications, including:  1. Image classification:\n",
      "CNNs can classify medical images into different categories, such as normal or\n",
      "abnormal, based on their visual features. 2. Object detection: CNNs can detect\n",
      "specific objects or features within medical images, such as tumors or fractures.\n",
      "3. Image segmentation: CNNs can segment medical images to identify specific\n",
      "regions of interest, such as tumors or organs.  The accuracy of CNNs in\n",
      "detecting abnormalities in medical imaging has been demonstrated in various\n",
      "studies. For example, research has shown that CNNs can achieve high accuracy in\n",
      "detecting breast cancer, lung nodules, and other abnormalities in medical\n",
      "images.  One of the key advantages of CNNs is their ability to learn from large\n",
      "datasets and improve their performance over time. This has led to significant\n",
      "advancements in medical imaging analysis and has the potential to revolutionize\n",
      "the field of radiology.  However, it's worth noting that the accuracy of CNNs\n",
      "can be affected by various factors, such as the quality of the images, the size\n",
      "and diversity of the training dataset, and the complexity of the task.\n",
      "Therefore, further research is needed to fully understand the potential of CNNs\n",
      "in radiology and to develop more accurate and reliable algorithms for medical\n",
      "image analysis.\u001b[0m\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Diabetes Insipidus\n",
    "response = query_engine.query(\n",
    "    \"What are the recommended dosages and administration methods for desmopressin in pediatric patients with diabetes insipidus, and are there any side effects or contraindications mentioned?\"\n",
    ")\n",
    "print_response(\"Desmopressin in Pediatric Diabetes Insipidus\", str(response))\n",
    "\n",
    "# Pulmonary Arterial Hypertension\n",
    "response = query_engine.query(\n",
    "    \"What are the success rates of combination therapies (e.g., endothelin receptor antagonists + phosphodiesterase-5 inhibitors) for pulmonary arterial hypertension, and are there any specific guidelines for pediatric patients?\"\n",
    ")\n",
    "print_response(\"Combination Therapies for Pulmonary Arterial Hypertension\", str(response))\n",
    "\n",
    "# COVID-19 Vaccines\n",
    "response = query_engine.query(\n",
    "    \"What are the specific strategies mentioned for improving COVID-19 vaccine efficacy in immunocompromised populations, and are there any clinical trial results supporting these strategies?\"\n",
    ")\n",
    "print_response(\"Strategies for COVID-19 Vaccines in Immunocompromised Populations\", str(response))\n",
    "\n",
    "# Cancer Immunotherapy\n",
    "response = query_engine.query(\n",
    "    \"What are the specific clinical outcomes of using biomimetic nanocarriers in cancer immunotherapy, and are there any ongoing clinical trials mentioned?\"\n",
    ")\n",
    "print_response(\"Biomimetic Nanocarriers in Cancer Immunotherapy\", str(response))\n",
    "\n",
    "# AI in Radiology\n",
    "response = query_engine.query(\n",
    "    \"What are the specific applications of convolutional neural networks (CNNs) in radiology, and how accurate are they in detecting abnormalities in medical imaging?\"\n",
    ")\n",
    "print_response(\"CNNs in Radiology\", str(response))"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
